We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-3.43%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.1B
AUM Growth
-$2.41B
(-7%)
Cap. Flow
-$988M
Cap. Flow
% of AUM
-3.08%
Top 10 Holdings %
Top 10 Hldgs %
22.71%
Holding
1,901
New
52
Increased
542
Reduced
1,211
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$52.1M |
| 2 |
PepsiCo
PEP
|
+$38.7M |
| 3 |
Target
TGT
|
+$34.6M |
| 4 |
Costco
COST
|
+$34.1M |
| 5 |
Trade Desk
TTD
|
+$33.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$426M |
| 2 |
NVIDIA
NVDA
|
+$377M |
| 3 |
Amazon
AMZN
|
+$236M |
| 4 |
Apple
AAPL
|
+$170M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.25% |
| 2 | Industrials | 11.99% |
| 3 | Consumer Staples | 11.34% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Healthcare | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Lyell Immunopharma
LYEL
$309M
| $57.3K | ﹤0.01% |
1,948
+12
| +0.6% | +$570 |
|
1702
Arcutis Biotherapeutics
ARQT
$3.42B
| $56.9K | ﹤0.01% |
10,708
+47
| +0.4% | +$400 |
|
1703
Planet Labs
PL
$7.3B
| $56.8K | ﹤0.01% |
21,851
-2,974
| -12% | -$9.45K |
|
1704
MaxCyte
MXCT
$116M
| $56.5K | ﹤0.01% |
18,120
+87
| +0.5% | +$350 |
|
1705
W&T Offshore
WTI
$545M
| $56K | ﹤0.01% |
12,774
-16
| -0.1% | -$66 |
|
1706
SIGA Technologies
SIGA
$223M
| $55.8K | ﹤0.01% |
10,633
+29
| +0.3% | +$143 |
|
1707
MacroGenics
MGNX
$235M
| $55.7K | ﹤0.01% |
11,955
+38
| +0.3% | +$189 |
|
1708
Community Health Systems
CYH
$385M
| $55.6K | ﹤0.01% |
19,167
-506
| -3% | -$1.88K |
|
1709
Arbutus Biopharma
ABUS
$865M
| $55.2K | ﹤0.01% |
27,170
+188
| +0.7% | +$394 |
|
1710
CleanSpark
CLSK
$3.73B
| $54.7K | ﹤0.01% |
+14,361
| New | +$75.8K |
|
1711
DocGo
DCGO
$58.9M
| $53.9K | ﹤0.01% |
10,104
-13
| -0.1% | -$106 |
|
|
ME
1712
DELISTED
23andMe Holding Co
ME
| $53K | ﹤0.01% |
2,710
+72
| +3% | +$2.02K |
|
1713
GoPro
GPRO
$116M
| $52.8K | ﹤0.01% |
16,813
-21
| -0.1% | -$80 |
|
|
AGEN
1714
Agenus
AGEN
$249M
| $51.4K | ﹤0.01% |
2,275
+44
| +2% | +$1.25K |
|
1715
Seres Therapeutics
MCRB
$48.1M
| $50K | ﹤0.01% |
1,051
+5
| +0.5% | +$382 |
|
|
TWKS
1716
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $49.1K | ﹤0.01% |
12,024
-19
| -0.2% | -$108 |
|
1717
Xeris Biopharma Holdings
XERS
$1.44B
| $48.9K | ﹤0.01% |
26,312
+122
| +0.5% | +$279 |
|
1718
Precigen
PGEN
$1.93B
| $48.6K | ﹤0.01% |
34,255
+151
| +0.4% | +$214 |
|
1719
Ocular Therapeutix
OCUL
$1.86B
| $48.1K | ﹤0.01% |
15,319
+153
| +1% | +$626 |
|
1720
Vanda Pharmaceuticals
VNDA
$312M
| $47.9K | ﹤0.01% |
11,098
-1,465
| -12% | -$8.14K |
|
|
SLGC
1721
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $46.9K | ﹤0.01% |
19,635
-23
| -0.1% | -$51 |
|
1722
Nautilus Biotechnolgy
NAUT
$215M
| $46.5K | ﹤0.01% |
14,726
+80
| +0.5% | +$260 |
|
1723
Atea Pharmaceuticals
AVIR
$379M
| $46.2K | ﹤0.01% |
15,411
+45
| +0.3% | +$153 |
|
|
TDAY
1724
USA Today Co
TDAY
$1.23B
| $45.9K | ﹤0.01% |
18,744
-22
| -0.1% | -$61 |
|
1725
EVgo
EVGO
$200M
| $44.9K | ﹤0.01% |
+13,275
| New | +$54.6K |
|
Similar funds
ProShare Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, ProShare Advisors held 1,901 positions worth $32.1B, down 7% from $34.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $988M in Q3 2023, closing 85 positions and reducing 1,211 holdings. Its most notable exit was DoorDash, an estimated $5.57M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in Trade Desk worth $32.3M.
- ProShare Advisors's largest Q3 2023 buy was Trade Desk: 413,129 shares worth $32.3M.
- ProShare Advisors added most to Broadcom in Q3 2023, an estimated $52.1M increase.
- ProShare Advisors's biggest Q3 2023 reduction was Microsoft, cutting an estimated $426M.
- ProShare Advisors fully exited DoorDash in Q3 2023, selling an estimated $5.57M.
- ProShare Advisors's ten largest holdings make up 23% of its $32.1B portfolio in Q3 2023.
- ProShare Advisors opened 52 new positions and closed 85 in Q3 2023.
- ProShare Advisors's portfolio value fell 7% quarter-over-quarter to $32.1B.
Based on ProShare Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.